KFI
Key Financial Inc Portfolio holdings
AUM
$497M
1-Year Return
13.15%
This Quarter Return
-0.19%
1 Year Return
+13.15%
3 Year Return
+47.67%
5 Year Return
+84.09%
10 Year Return
–
AUM
$440M
AUM Growth
-$12.6M
(-2.8%)
Cap. Flow
-$8.11M
Cap. Flow
% of AUM
-1.84%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
1,411
New
60
Increased
272
Reduced
114
Closed
30
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 14.33% |
| 2 | Financials | 4.92% |
| 3 | Healthcare | 4.9% |
| 4 | Consumer Discretionary | 3.6% |
| 5 | Consumer Staples | 2.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
AstraZeneca
AZN
$253B
| $508K | 0.12% |
7,754
+37
| +0.5% | +$2.42K |
|
152
Marriott International Class A Common Stock
MAR
$71.9B
| $507K | 0.12% |
1,818
+184
| +11% | +$51.3K |
|
153
iShares Morningstar Value ETF
ILCV
$1.09B
| $500K | 0.11% |
6,169
+750
| +14% | +$60.7K |
|
154
iShares Russell 2000 Value ETF
IWN
$11.9B
| $496K | 0.11% |
3,022
-1
| -0% | -$164 |
|
155
General Mills
GIS
$26.9B
| $488K | 0.11% |
7,650
-1,322
| -15% | -$84.3K |
|
156
Sabesp
SBS
$15.8B
| $456K | 0.1% |
31,830
| – | – |
|
157
Vanguard Dividend Appreciation ETF
VIG
$95.7B
| $455K | 0.1% |
2,323
| – | – |
|
158
Paychex
PAYX
$48.2B
| $452K | 0.1% |
3,221
| – | – |
|
159
Lowe's Companies
LOW
$151B
| $442K | 0.1% |
1,791
-322
| -15% | -$79.5K |
|
160
Thomson Reuters
TRI
$78.8B
| $442K | 0.1% |
2,753
| – | – |
|
161
IBM
IBM
$230B
| $441K | 0.1% |
2,007
-35
| -2% | -$7.69K |
|
162
Kimberly-Clark
KMB
$43B
| $425K | 0.1% |
3,244
-380
| -10% | -$49.8K |
|
163
Union Pacific
UNP
$130B
| $421K | 0.1% |
1,847
+64
| +4% | +$14.6K |
|
164
Pinnacle West Capital
PNW
$10.6B
| $415K | 0.09% |
4,900
| – | – |
|
165
Consolidated Edison
ED
$35.2B
| $404K | 0.09% |
4,533
| – | – |
|
166
iShares Russell 2000 Growth ETF
IWO
$12.5B
| $401K | 0.09% |
1,394
| – | – |
|
167
Thermo Fisher Scientific
TMO
$186B
| $401K | 0.09% |
770
+21
| +3% | +$10.9K |
|
168
Aflac
AFL
$57.1B
| $400K | 0.09% |
3,865
| – | – |
|
169
Corteva
CTVA
$48.5B
| $394K | 0.09% |
6,921
| – | – |
|
170
Morgan Stanley
MS
$236B
| $393K | 0.09% |
3,127
+310
| +11% | +$39K |
|
171
Gilead Sciences
GILD
$142B
| $393K | 0.09% |
4,253
+20
| +0.5% | +$1.85K |
|
172
3M
MMM
$82.6B
| $390K | 0.09% |
3,022
+1
| +0% | +$129 |
|
173
iShares MSCI USA Quality Factor ETF
QUAL
$54.1B
| $388K | 0.09% |
2,180
+164
| +8% | +$29.2K |
|
174
Bristol-Myers Squibb
BMY
$95.4B
| $387K | 0.09% |
6,839
-131
| -2% | -$7.41K |
|
175
iShares MSCI EAFE ETF
EFA
$66.2B
| $386K | 0.09% |
5,104
+30
| +0.6% | +$2.27K |
|